Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluconazole vs Amphotericin B in Cryptococcal Meningitis
NCT00002305Phase 3Completed
- Sponsor
- Pfizer
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of fluconazole in cryptococcal meningitis (2 arms), sponsored by Pfizer. Primary endpoints: Clinical Success Rate at 10 weeks and Mycologic Success Rate at 10 weeks. Status: completed.
02
Drugs
fluconazole
03
Conditions
cryptococcal meningitis
Beyond the preview
Go deeper on NCT00002305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002305.